prikaz prve stranice dokumenta Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review
  Download
PDF 104.81 KB
Scientific paper - Case study
Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review
Croatian Medical Journal, 59 (2018), 6; 307-312. https://doi.org/10.3325/cmj.2018.59.307
Medved, Sara; Ostojić, Zvonimir; Jurin, Hrvoje; Medved, Vesna

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Medved, S., Ostojić, Z., Jurin, H. & Medved, V. (2018). Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review. Croatian Medical Journal, 59. (6), 307-312. doi: 10.3325/cmj.2018.59.307

Medved, Sara, et al. "Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review." Croatian Medical Journal, vol. 59, no. 6, 2018, pp. 307-312. https://doi.org/10.3325/cmj.2018.59.307

Medved, Sara, Zvonimir Ostojić, Hrvoje Jurin and Vesna Medved. "Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review." Croatian Medical Journal 59, no. 6 (2018): 307-312. https://doi.org/10.3325/cmj.2018.59.307

Medved, S., et al. (2018) 'Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review', Croatian Medical Journal, 59(6), pp. 307-312. doi: 10.3325/cmj.2018.59.307

Medved S, Ostojić Z, Jurin H, Medved V. Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review. Croatian Medical Journal [Internet]. 2018 December 31 [cited 2024 November 28];59(6):307-312. doi: 10.3325/cmj.2018.59.307

S. Medved, Z. Ostojić, H. Jurin and V. Medved, "Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review", Croatian Medical Journal, vol. 59, no. 6, pp. 307-312, December 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:636370. [Accessed: 28 November 2024]

Metadata
Title (english)Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review
AuthorSara Medved
AuthorZvonimir Ostojić
AuthorHrvoje Jurin
AuthorVesna Medved
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Takotsubo cardiomyopathy (TC) is a rare complication of electroconvulsive therapy (ECT), an effective and safe treatment for severe cases of depression and psychosis. There are reports on 16 patients who developed TC after ECT, and these were predominantly female patients treated with antidepressants for depressive disorder. We describe a case of a 40-year-old male patient, with a history of schizophrenia and heavy caffeine and nicotine use, treated for acute psychotic episode with haloperidol and clozapine. Propranolol was administered because of clozapine-induced tachycardia. After 8 weeks without therapeutic response, the patient was referred for standard ECT procedure, which included premedication and bifrontotemporal stimulation. Two hours later, the patient experienced gastric pain and had increased troponin and natriuretic peptide levels and ST-elevation. After inotrope and anticoagulant treatment and replacement of antipsychotics, the patient remained stable. Contrary to common opinion, previous adrenergic blockade in this patient did not prevent TC occurrence. TC pathophysiology remains unclear although it has been related to the burst of norepinephrine neurons. Psychosis has also been associated with catecholamine dysfunction, and excessive psychological stress with long-term norepinephrine dysfunction. Animal models have shown that ECT, clozapine, and nicotine and caffeine use could considerably increase catecholamine levels. Clinical understanding of rare cardiac ECT complications could improve early recognition of patients at risk for TC and ensure safe ECT protocols.
Keywords (english)
Languageenglish
Publication typeScientific paper - Case study
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleCroatian Medical Journal
Numberingvol. 59, no. 6, pp. 307-312
p-ISSN0353-9504
DOIhttps://doi.org/10.3325/cmj.2018.59.307
URN:NBNurn:nbn:hr:105:636370
Publication2018-12-31
Document URLhttp://doi.org/10.3325/cmj.2018.59.307
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 09:49:40